ARTICLE | Clinical News
Allon preclinical data
February 7, 2011 8:00 AM UTC
In a mouse model of PD, intranasal davunetide for 2 months significantly improved motor performance and coordination by 38% vs. vehicle-treated controls (p<0.01). Data were published in Molecular and ...